Cargando…
Fibroblast activation protein (FAP) as a novel metabolic target
OBJECTIVE: Fibroblast activation protein (FAP) is a serine protease belonging to a S9B prolyl oligopeptidase subfamily. This enzyme has been implicated in cancer development and recently reported to regulate degradation of FGF21, a potent metabolic hormone. Using a known FAP inhibitor, talabostat (T...
Autores principales: | Sánchez-Garrido, Miguel Angel, Habegger, Kirk M., Clemmensen, Christoffer, Holleman, Cassie, Müller, Timo D., Perez-Tilve, Diego, Li, Pengyun, Agrawal, Archita S., Finan, Brian, Drucker, Daniel J., Tschöp, Matthias H., DiMarchi, Richard D., Kharitonenkov, Alexei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034526/ https://www.ncbi.nlm.nih.gov/pubmed/27689014 http://dx.doi.org/10.1016/j.molmet.2016.07.003 |
Ejemplares similares
-
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018) -
Glucagon receptor signaling regulates weight loss via central KLB receptor complexes
por: Nason, Shelly R., et al.
Publicado: (2021) -
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
por: Jall, Sigrid, et al.
Publicado: (2017) -
GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017) -
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
por: Mroz, Piotr A., et al.
Publicado: (2018)